Senator Tillis on PBM Reform: Past Failures and the Need for Modernization
Forbes Breaking NewsJune 7, 20255 min1,133 views
8 connections·10 entities in this video→The Problem with Current PBM Reform Discussions
- 🗣️ Senator Tillis argues that discussions around Pharmacy Benefit Managers (PBMs) often involve people talking past each other, focusing on a single target like pharma or PBMs without considering the entire value chain.
- 💡 This approach leads to spinning wheels and picking favorite targets instead of achieving meaningful reform.
Consequences of Policy Decisions
- 📉 Tillis points to the Affordable Care Act (ACA) as an example where, while pharma faced cuts, there was a 60% reduction in small molecule research, a critical field for future therapies.
- ⚠️ He questions why companies would publicly state such reductions if they were not genuinely impacted by policy decisions.
The Need for Transparency and Audit
- 🔍 Tillis highlights the difficulty in obtaining transparency, even from his own PBM, Tricare, for federal employees.
- 📝 He has repeatedly requested an audit of Tricare to understand pricing within the "black box" but has only received heavily redacted reports.
- 🏛️ He plans to try again with the current administration to audit their own PBM.
Modernizing PBMs and Ensuring Patient Focus
- 🎯 Tillis believes the mission of PBMs has varied dramatically since their inception, and it's crucial to determine if this "mission creep" is value-added or cost-adding.
- 🚀 The right-minded approach, he suggests, is to modernize PBMs, understand their value-add, implement price transparency, and ultimately create something with enduring value for the patient.
- 🤝 He advocates for getting all players into a "barbershop" for a comprehensive discussion on fixing the value chain, rather than using hearings to demonize specific links.
Fiduciary Duty and Transparency
- ❓ A question is raised about PBMs operating as fiduciaries, with the understanding that they recommend and administer benefits at the direction of employers, not making decisions for plan sponsors.
- 📊 Tillis notes that the industry has leaned in to embrace transparency and is willing to work with Congress to set a floor for transparency, allowing clients to choose additional data add-ons.
Knowledge graph10 entities · 8 connections
How they connect
An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.
Hover · drag to explore
10 entities
Chapters3 moments
Key Moments
Transcript22 segments
Full Transcript
Topics10 themes
What’s Discussed
Pharmacy Benefit Managers (PBMs)PBM ReformHealthcare Value ChainPrice TransparencySmall Molecule ResearchTricareHealthcare PolicyPatient AdvocacyFiduciary DutyACA
Smart Objects10 · 8 links
Companies· 3
Concepts· 6
Person· 1